Awesome news and working swiftly to extract the benefits from the strategic acquisition:
TGA approval has been received for Imbio products. The company didn’t announce this but I think this would have been worthy of an announcement.
And following on from TGA approval:
”Targeting rollout of Imbio products in Australia in 2H2024”
“New partner discussions well advanced” for Imbio product (assume for companion diagnostics, similar to agreements with Olympus, Riverain and Genentech)
2nd ATO is still being targeted. Lots happening per the update and still more things happening outside of this too.
Ann: 1H FY2024 Investor Presentation, page-2
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
60.0¢ |
Change
0.045(8.11%) |
Mkt cap ! $234.8M | |||
| Open | High | Low | Value | Volume |
| 56.0¢ | 63.0¢ | 56.0¢ | $1.032M | 1.754M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 25344 | 60.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.5¢ | 12813 | 1 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
60.5¢ |
Change
0.045 ( 8.07 %) |
||||
| Open | High | Low | Volume | ||
| 56.5¢ | 63.0¢ | 56.5¢ | 362264 | ||
| Last updated 15.58pm 10/05/2024 ? | |||||
| 4DX (ASX) Chart |